AU1101397A - 4,10beta-diacetoxy-2alpha-benzoyloxy-5beta, 20-epoxy-1- hydroxy-9-oxo-19-norcyclopropa(g)tax-11-en-13alpha-yl (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3- phenylpropionate dihydrate and its process of preparation - Google Patents

4,10beta-diacetoxy-2alpha-benzoyloxy-5beta, 20-epoxy-1- hydroxy-9-oxo-19-norcyclopropa(g)tax-11-en-13alpha-yl (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3- phenylpropionate dihydrate and its process of preparation

Info

Publication number
AU1101397A
AU1101397A AU11013/97A AU1101397A AU1101397A AU 1101397 A AU1101397 A AU 1101397A AU 11013/97 A AU11013/97 A AU 11013/97A AU 1101397 A AU1101397 A AU 1101397A AU 1101397 A AU1101397 A AU 1101397A
Authority
AU
Australia
Prior art keywords
hydroxy
norcyclopropa
10beta
13alpha
5beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU11013/97A
Other versions
AU713086B2 (en
AU713086C (en
Inventor
Jean-Rene Authelin
Eric Didier
Michel Lavigne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9485512&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU1101397(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Publication of AU1101397A publication Critical patent/AU1101397A/en
Publication of AU713086B2 publication Critical patent/AU713086B2/en
Assigned to AVENTIS PHARMA S.A. reassignment AVENTIS PHARMA S.A. Request to Amend Deed and Register Assignors: RHONE-POULENC RORER S.A.
Application granted granted Critical
Publication of AU713086C publication Critical patent/AU713086C/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
AU11013/97A 1995-12-14 1996-12-09 4,10beta-diacetoxy-2alpha-benzoyloxy-5beta, 20-epoxy-1- hydroxy-9-oxo-19-norcyclopropa(g)tax-11-en-13alpha-yl (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3- phenylpropionate dihydrate and its process of preparation Ceased AU713086C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR95/14841 1995-12-14
FR9514841A FR2742438B1 (en) 1995-12-14 1995-12-14 (2R, 3S) DIHYDRATE -3-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY- 3-PHENYLPROPIONATE OF 4,10BETA-DIACETOXY-2ALPHA-BENZOYLOXY- 5BETA, 2O-EPOXY-1-HYDROX CYCLOPROPA (G) TAX-11- ENE-13ALPHA-YLE, AND PREPARATION METHOD THEREOF
PCT/FR1996/001957 WO1997021695A1 (en) 1995-12-14 1996-12-09 4,10β-DIACETOXY-2α-BENZOYLOXY-5β,20-EPOXY-1-HYDROXY-9-OXO-19-NOR-CYCLOPROPA[G]TAX-11-ENE-13α-YL (2R,3S)-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE DIHYDRATE, AND METHOD FOR PREPARING SAME

Publications (3)

Publication Number Publication Date
AU1101397A true AU1101397A (en) 1997-07-03
AU713086B2 AU713086B2 (en) 1999-11-25
AU713086C AU713086C (en) 2002-09-19

Family

ID=9485512

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11013/97A Ceased AU713086C (en) 1995-12-14 1996-12-09 4,10beta-diacetoxy-2alpha-benzoyloxy-5beta, 20-epoxy-1- hydroxy-9-oxo-19-norcyclopropa(g)tax-11-en-13alpha-yl (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3- phenylpropionate dihydrate and its process of preparation

Country Status (37)

Country Link
EP (1) EP0876361B1 (en)
JP (1) JP4059351B2 (en)
KR (1) KR100429330B1 (en)
CN (1) CN101113143A (en)
AR (1) AR004380A1 (en)
AT (1) ATE204573T1 (en)
AU (1) AU713086C (en)
BG (1) BG63010B1 (en)
BR (1) BR9611957A (en)
CA (1) CA2236545C (en)
CO (1) CO4810227A1 (en)
CZ (1) CZ288998B6 (en)
DE (1) DE69614716T2 (en)
DK (1) DK0876361T3 (en)
DZ (1) DZ2140A1 (en)
EA (1) EA000668B1 (en)
ES (1) ES2162123T3 (en)
FR (1) FR2742438B1 (en)
GR (1) GR3036437T3 (en)
HU (1) HU224962B1 (en)
IL (1) IL124766A (en)
IN (1) IN185809B (en)
MY (1) MY115886A (en)
NO (1) NO317356B1 (en)
NZ (1) NZ323964A (en)
OA (1) OA11012A (en)
PL (1) PL187613B1 (en)
PT (1) PT876361E (en)
RO (1) RO115880B1 (en)
SK (1) SK282512B6 (en)
TN (1) TNSN96157A1 (en)
TR (1) TR199801087T2 (en)
TW (1) TW358093B (en)
UA (1) UA55401C2 (en)
UY (1) UY24387A1 (en)
WO (1) WO1997021695A1 (en)
ZA (1) ZA9610200B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102851740A (en) * 2011-06-30 2013-01-02 复旦大学 Fluorinated docetaxel crystal and its preparation method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2698871B1 (en) * 1992-12-09 1995-02-24 Rhone Poulenc Rorer Sa New taxoids, their preparation and the pharmaceutical compositions containing them.

Also Published As

Publication number Publication date
AR004380A1 (en) 1998-11-04
MY115886A (en) 2003-09-30
CA2236545A1 (en) 1997-06-19
NO982561L (en) 1998-06-04
NO317356B1 (en) 2004-10-18
DZ2140A1 (en) 2002-07-23
GR3036437T3 (en) 2001-11-30
KR19990072107A (en) 1999-09-27
HUP9904048A3 (en) 2001-08-28
FR2742438B1 (en) 1998-01-16
EP0876361A1 (en) 1998-11-11
BR9611957A (en) 1999-02-17
DE69614716D1 (en) 2001-09-27
EA199800452A1 (en) 1998-12-24
ZA9610200B (en) 1997-06-23
PL187613B1 (en) 2004-08-31
CO4810227A1 (en) 1999-06-30
EA000668B1 (en) 2000-02-28
CZ288998B6 (en) 2001-10-17
NO982561D0 (en) 1998-06-04
AU713086B2 (en) 1999-11-25
AU713086C (en) 2002-09-19
BG63010B1 (en) 2001-01-31
TNSN96157A1 (en) 2005-03-15
DK0876361T3 (en) 2001-10-08
CZ183098A3 (en) 1998-09-16
PL327451A1 (en) 1998-12-07
ATE204573T1 (en) 2001-09-15
NZ323964A (en) 2000-01-28
IN185809B (en) 2001-05-05
FR2742438A1 (en) 1997-06-20
MX9804604A (en) 1998-10-31
CN101113143A (en) 2008-01-30
BG102535A (en) 1999-08-31
UY24387A1 (en) 2001-08-27
HU224962B1 (en) 2006-04-28
JP2000501722A (en) 2000-02-15
SK282512B6 (en) 2002-10-08
PT876361E (en) 2001-11-30
ES2162123T3 (en) 2001-12-16
TR199801087T2 (en) 1998-09-21
IL124766A0 (en) 1999-01-26
EP0876361B1 (en) 2001-08-22
WO1997021695A1 (en) 1997-06-19
DE69614716T2 (en) 2002-06-27
IL124766A (en) 2001-03-19
JP4059351B2 (en) 2008-03-12
CA2236545C (en) 2007-01-30
HUP9904048A1 (en) 2001-04-28
OA11012A (en) 2003-03-06
UA55401C2 (en) 2003-04-15
KR100429330B1 (en) 2005-01-13
SK79098A3 (en) 1998-11-04
RO115880B1 (en) 2000-07-28
TW358093B (en) 1999-05-11

Similar Documents

Publication Publication Date Title
AU679663B2 (en) Dermatological or pharmaceutical composition, preparation process and use
AU5278096A (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing same
EP0811595A4 (en) Hydrochalcone derivatives, comestic compositions containing the same, and processes for the preparation of both
AU5925296A (en) Relaxin analogs and derivatives methods and uses thereof
AU1180997A (en) Novel taxoids, their preparation and pharmaceutical compositions containing them
AUPN411195A0 (en) Medicinal composition
AU6124296A (en) Novel dolastatin derivatives, their preparation and use
AU1245297A (en) Preparation of 1,1,1,3,3-pentachlorobutane and 1,1,1,3,3-pentafluorobutane
AU4329396A (en) Use of 3,4-diphenylchromans
AU5108196A (en) Imidazoquinazolines, drugs containing these compounds, their use and process for their preparation
AUPN089295A0 (en) Treatment of diabetic neuropathy
AU6328696A (en) Treatment of hemoglobinopathies
AU5402896A (en) New taxoids, their preparation and pharmaceutical compositions containing same
AU5798996A (en) Adnaz, compositions and processes
AU3473695A (en) Novel 4-aminopyridazines, method of preparing them and drugs containing these compounds
AU5058196A (en) Process for the preparation of 1,1-difluoroethane
AU4729396A (en) Process for the preparation of 1,2-benzisothiazolin-3-ones
AU4442996A (en) Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for the production of pharmaceutical preparations, and pharmaceutical preparations containing them
AU713086C (en) 4,10beta-diacetoxy-2alpha-benzoyloxy-5beta, 20-epoxy-1- hydroxy-9-oxo-19-norcyclopropa(g)tax-11-en-13alpha-yl (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3- phenylpropionate dihydrate and its process of preparation
AU681054B2 (en) Novel glycoproteins, process for preparation thereof, and pharmaceutical composition
AU1180897A (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing same
AU4568396A (en) Process for the preparation of ivermectin
AU5348694A (en) Octahydronaphthoquinolizines, and methods of making and using thereof
AU5272296A (en) Benzopyranopyrrole compounds, their preparation and use
AU6418396A (en) Epimers of (22RS)-N-(1,1,1-trifluoro-2-phenylprop-2-yl)-3-ox-4-aza-5alp ha-androst-1-ene-17beta-carboxamide

Legal Events

Date Code Title Description
HB Alteration of name in register

Owner name: AVENTIS PHARMA S.A.

Free format text: FORMER NAME WAS: RHONE-POULENC RORER S.A.

DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE PROPOSED AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 20020207

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS WAS NOTIFIED IN THE OFFICIAL JOURNAL DATED 20020307